Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2002-04-29 | During 2001, each director who was not an employee of the Company was entitled to receive a director's fee of $10,000 and immediately exercisable options for 13,500 shares of Common Stock under the Stock Option Plan. The number of stock options granted was valued at approximately $10,000 using the Black-Scholes method. In addition, each non-employee director is entitled to be paid $1,000 for each Board meeting or committee meeting attended in person or regular Board meetings attended telephonically and $500 for each special Board meeting or committee meeting attended telephonically. |
| 2003-04-30 | During 2002, each director who was not an employee of Anika Therapeutics received a director's fee of $10,000 and immediately exercisable options for 11,800 shares of Common Stock under the Anika Therapeutics, Inc. 1993 Stock Option Plan (the "1993 Stock Option Plan"). The number of stock options granted was valued at approximately $10,000 using the Black-Scholes method. |
| 2004-04-29 | Dr. Sadow joined the Board of Directors of Anika Therapeutics in December 1995. He serves on the Nominating Committee. Compensation for non-employee Directors in 2003 was $10,000 cash and options valued at $10,000. For fiscal 2004, the cash portion was increased to $20,000. |
| 2005-04-29 | Dr. Sadow joined the Board of Directors of Anika Therapeutics in December 1995. The Nominating Committee members include Mr. Wheeler (Chairperson), Dr. Bower, Dr. Davidson, Mr. McKay and Dr. Sadow. During 2004, each Director who was not an employee of Anika Therapeutics received a director's fee of $20,000. In addition, each non-employee director was paid $1,000 for each Board meeting or committee meeting attended in person or regular Board meetings attended telephonically and $500 for each special Board meeting or committee meeting attended telephonically. Annually, each non-employee Director is also entitled to receive immediately exercisable options for shares of Common Stock under the Anika Therapeutics, Inc. 2003 Stock Option and Incentive Plan (the "2003 Plan"). The number of stock options granted is valued at approximately $10,000 using the Black-Scholes method and based on the market value of Anika Therapeutics' common stock on the date of grant. Options with respect to 2004 were awarded following the end of the 2004 fiscal year. |
| 2006-04-24 | Dr. Sadow joined the Board of Directors of Anika Therapeutics in December 1995. The Nominating Committee members include Dr. Sadow. For fiscal year 2005, each director who was not an employee of Anika Therapeutics received a director's fee of $20,000. |
Data sourced from SEC filings. Last updated: 2026-02-03